Seres Therapeutics, Inc.
Seres Therapeutics, Inc. scores highest on Anchor (56) and lowest on Nitro (9). Its PosiPenta is 30.33 out of 100, weaker than most similar companies.
On the Penta Grid this week, Seres Therapeutics, Inc. is Grid #756 of 837 in the Healthcare sector in United States, and Grid #3,597 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Seres Therapeutics, Inc. | 30.33 | 43 | 18 | 9 | 26 | 56 |
| TherapeuticsMD, Inc. | 60.75 | 42 | 87 | 67 | 58 | 50 |
| Aytu BioPharma, Inc. | 51.96 | 44 | 64 | 58 | 39 | 55 |
| NextCure, Inc. | 33.16 | 26 | 27 | 48 | 24 | 41 |
| InspireMD, Inc. | 38.07 | 43 | 48 | 13 | 33 | 53 |
| Context Therapeutics Inc. | 37.05 | 45 | 45 | 10 | 57 | 28 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.02 |
| P/B ratio | 0.72 |
EEarnings
| Trailing EPS | ₹-229.21 |
| Forward EPS | ₹-468.37 |
NNitro
| Price | 233.00 |
| 52-week high | 2839.55 |
| 52-week low | 225.90 |
| Fall from 52-week high | 91.8% |
TTorque
| Return on equity (ROE) | -66.57% |
| Debt-to-equity | 1.64 |
AAnchor
| Beta (price swings) | 0.31 |
| Market cap | ₹234 Cr |
| Insider holding | 11.49% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Seres Therapeutics, Inc.'s PosiPenta score?
Seres Therapeutics, Inc.'s PosiPenta is 30.33 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Seres Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Seres Therapeutics, Inc. is Grid #756 of 837 in the Healthcare sector in United States, and Grid #3,597 of 4,000 in United States.
Which PosiPenta pillar is strongest for Seres Therapeutics, Inc.?
Anchor (stability and dividends), with a score of 56 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Seres Therapeutics, Inc.?
Nitro (momentum), with a score of 9 out of 100: much weaker than most similar companies.
Has Seres Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.26 points, from 27.07 to 30.33.
PositoAI is for research and education only and is not investment advice.